Results 41 to 50 of about 72,717 (274)
External radiotherapy of thyroid cancer [PDF]
, 2001 Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Dühmke, Eckhart, Pollinger, B.
core +1 more source
Utility of P63 in Differentiating Giant Cell Tumor from Other Giant Cell-Containing Lesions
Türk Patoloji Dergisi, 2022 Objective: To assess P63 expression in giant cell-containing lesions of the bone (GCLB) and to determine its utility in differentiating giant cell tumor of the bone (GCTB) from other GCLBs.
Monalisa HUI +5 more
doaj +1 more source
A chondroblastic osteosarcoma of the coronoid process mimicking a fragmented coronoid process in a dog [PDF]
, 2016 A 6-year-old Rhodesian Ridgeback was presented with a 1.5 year history of right forelimb lameness. Clinical, radiological and computed tomographic findings suggested the presence of fragmented medial coronoid process.
Cirkel, Koen +4 more
core +1 more source
Giant Cell Tumor of Bone in Patients under 16 Years Old: A Single-Institution Case Series
Cancers, 2021 Simple Summary Giant cell tumor of the bone is a locally aggressive, rarely metastasizing tumor that accounts for about 5% of bone tumors; it generally occurs in patients between 20 and 45 years old.
F. Ambrosi +8 more
semanticscholar +1 more source
Journal of Bone Oncology, 2019 Background: Although denosumab has been approved as an antiresorptive agent for giant cell tumor of bone, its efficacy has not been proven. Objectives: To compare the efficacy and safety of denosumab and zoledronic acid treatment in patients with ...
Shenglong Li, Peng Chen, Qiankun Yang
doaj +1 more source
Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study [PDF]
, 1999 Objective: In a prospective multicenter trial, it was our intention to elucidate clinical prognostic factors of seminomas with special reference to the importance of human chorionic gonadotropin (HCG) elevations in histologically pure seminomas. Methods:
Bussar-Maatz, R. +7 more
core +1 more source
Folia Medica, 2018 Giant cell tumor of bone is a histologically benign but locally aggressive osteolytic lesion, capable of spreading ‘benign’ metastases mainly to the lungs. Since its description as a separate entity, surgery has been the mainstay of treatment.
Marinova Violeta V. +4 more
doaj +1 more source
Journal of the Bulgarian Orthopaedics and Trauma Association, 2023 Giant cell tumor of bone is a histologically benign bone neoplasia that clinically has an aggressive course. In rare cases, it can give "benign" lung metastases or undergo malignant transformation.
Luben Stokov +4 more
doaj +3 more sources
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone [PDF]
, 2016 Denosumab is a monoclonal antibody to RANK ligand approved for use in giant cell tumour (GCT) of bone. Due to its efficacy, Denosumab is recommended as the first option in inoperable or metastatic GCT.
Angelo Paolo Dei Tos +15 more
core +1 more source
Malignancy in Giant Cell Tumor of Bone: A Review of the Literature
Technology in Cancer Research and Treatment, 2019 Background: Primary and recurrent giant cell tumor of bone is typically benign; however, rarely giant cell tumor of bone can undergo malignant transformation.
E. Palmerini +3 more
semanticscholar +1 more source